QPPV.COM KNOWLEDGE ASSESSMENT

Audit Findings and Classification in Pharmacovigilance โ€” Knowledge Assessment

Test your understanding of the concepts covered by Audit Findings and Classification in Pharmacovigilance.

Question 1 of 10Pass mark: 80%

Question 1 of 10 What is the most appropriate role of QA or the audit owner in the classification process?
Question 2 of 10 What is the best immediate response when a finding suggests a serious and ongoing risk to patient safety?
Question 3 of 10 Which metric is most useful for detecting weakness in the organization's overall finding-management system?
Question 4 of 10 Which item is most appropriate as documented containment for a suspected safety-data integrity failure?
Question 5 of 10 What is the key distinction between CAPA implementation evidence and CAPA effectiveness evidence?
Question 6 of 10 Which proposed CAPA provides the strongest evidence of an effectiveness-oriented design?
Question 7 of 10 Which characteristic most clearly distinguishes a regulatoryly usable audit finding from an auditor's opinion?
Question 8 of 10 Which example best illustrates why classification should not rely on patient harm that has already occurred as the only criterion?
Question 9 of 10 A PV audit identifies repeated delayed safety reporting across several products, but there is no evidence of an immediate serious patient harm event. Which interpretation best fits the framework?
Question 10 of 10 A previous CAPA was closed, but the same type of finding recurs. What is the most appropriate governance response?

Select an answer to continue.